15h
MedPage Today on MSNClotting Risk Worse Than Expected in Protein S-Deficient PatientsCarriers of these high-risk variants had total protein S levels that were about half of normal. Less severe gene variants ...
Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...
18h
GlobalData on MSNNovo Nordisk and AI-driven Gensaic enter into $354m cardiometabolic dealNovo Nordisk has signed a deal with AI-driven protein design company Gensaic to develop tissue-targeted therapies for ...
AstraZeneca has opened a plant to produce biogas from organic waste that will ensure by the end of this year all of its ...
17h
GlobalData on MSNNovo Holdings and TA Associates back BiocompositesNovo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its ...
Stifel Nicolaus cut shares of Novo Nordisk A/S (NYSE:NVO – Free Report) from a buy rating to a hold rating in a report issued ...
We recently published an article titled Jim Cramer Discusses These 12 Stocks & Says Late Selloffs Are Deliberate. In this ...
It's the second year in a row that Lilly has used the Oscars as a platform to drive home a message about GLP-1-based obesity ...
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
AbbVie on Monday jumped into the hot weight-loss space, looking to gain ground on its Big Pharma peers, with a licensing deal ...
20h
Hosted on MSNIs Trending Stock Novo Nordisk A/S (NVO) a Buy Now?Novo Nordisk (NVO) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares ...
California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results